HAEMONETICS CORP — Director's Dealing 2015

Aug 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-08-20

Reporting Person: LINDOP CHRISTOPHER J (CFO & EVP Business Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-20	Common Stock	M	4902.0	$26.315	Acquired	43090	Direct
2015-08-20	Common Stock	S	4902.0	$38.492	Disposed	38188	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-08-20	Non-Qualified Stock Option (right to buy)	$26.315	M	4902.0	Disposed	2015-10-23	Common Stock (4902)	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan.

F2: Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.